Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-002734
Filing Date
2017-01-24
Accepted
2017-01-24 17:45:19
Documents
1
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6032
  Complete submission text file 0001140361-17-002734.txt   7456
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 36 ROCKLAND MILLS ROCKLAND DE 19732
Business Address
Nolan Lisa (Reporting) CIK: 0001661400 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 17544635